Hybrid compound design to overcome the gatekeeper T338M mutation in cSrc
Getlik, M., Grutter, C., Simard, J.R., Kluter, S., Rabiller, M., Rode, H.B., Robubi, A., Rauh, D.(2009) J Med Chem 52: 3915-3926
- PubMed: 19462975 
- DOI: 10.1021/jm9002928
- Primary Citation of Related Structures:  
3F3V, 3F3W, 3G5D - PubMed Abstract: 
The emergence of drug resistance remains a fundamental challenge in the development of kinase inhibitors that are effective over long-term treatments. Allosteric inhibitors that bind to sites lying outside the highly conserved ATP pocket are thought to be more selective than ATP-competitive inhibitors and may circumvent some mechanisms of drug resistance ...